Advertisement
Table 3 A cross-study comparison of long term survival data and early death rates of the patients with HNSCC from Basel and patients with HNSCC who had been treated within published clinical trials with concurrent chemo-radiotherapy
| Study | Year | 3-OS (in %) | 5-OS (in %) | Early mortality (patients) |
|---|---|---|---|---|
| Bonner et. al. | 2006 | 55 | 40* | 11/211 (5%) |
| Huguenin et. al. | 2004 | 59° | 46 | 0/112 (0%) |
| Calais et. al. | 1999 | 51 | - | 1/109 (1%) |
| Merlano et. al. | 1996 | 38* | 24 | not reported |
| Adelstein et. al. | 2000 | 37 | 28* | 6/96 (6%) |
| Wendt et. al. | 1998 | 49 | - | 4/256 (2%) |
| Brizel et. al. | 1998 | 55 | 48* | 1/56 (2%) |
| Al-Sarraf et. al. | 1998 | 78 | 68* | 1/78 (1%) |
| Data from Basel | 1994-2007 | 54 | 47 | 9/167 (5%) |
| - Therapy before 2000 | 43 | 33 | ||
| - Therapy after 2000 | 65 | 61 |
